AA
CVS icon

ALPS Advisors’s CVS Health CVS Stock Holding History

ALPS Advisors’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$24.9M Buy
346,043
+30,181
+10% +$2.32M 0.12% 114
2025
Q4 		$25.1M Sell
315,862
-11,352
-3% -$895K 0.15% 96
2025
Q3 		$24.7M Sell
327,214
-21,159
-6% -$1.45M 0.14% 92
2025
Q2 		$24M Sell
348,373
-19,446
-5% -$1.28M 0.14% 83
2025
Q1 		$24.9M Sell
367,819
-122,881
-25% -$7.35M 0.14% 77
2024
Q4 		$22M Buy
+490,700
New +$27.5M 0.14% 100
2024
Q3 		– Sell
-18,326
Closed -$1.08M – 1036
2024
Q2 		$1.08M Sell
18,326
-948
-5% -$59.3K 0.01% 447
2024
Q1 		$1.54M Sell
19,274
-633
-3% -$48.4K 0.01% 394
2023
Q4 		$1.57M Sell
19,907
-1,267
-6% -$90.2K 0.01% 370
2023
Q3 		$1.48M Buy
21,174
+16,193
+325% +$1.15M 0.01% 372
2023
Q2 		$344K Sell
4,981
-124
-2% -$8.82K ﹤0.01% 745
2023
Q1 		$379K Sell
5,105
-2,843
-36% -$238K ﹤0.01% 644
2022
Q4 		$741K Sell
7,948
-705
-8% -$68K 0.01% 531
2022
Q3 		$825K Buy
8,653
+5,354
+162% +$530K 0.01% 505
2022
Q2 		$306K Buy
3,299
+380
+13% +$37.1K ﹤0.01% 787
2022
Q1 		$295K Sell
2,919
-909
-24% -$95.5K ﹤0.01% 770
2021
Q4 		$395K Buy
+3,828
New +$354K ﹤0.01% 678
2021
Q1 		– Sell
-4,554
Closed -$311K – 892
2020
Q4 		$311K Sell
4,554
-93
-2% -$6.05K ﹤0.01% 691
2020
Q3 		$271K Buy
4,647
+1,164
+33% +$72.4K ﹤0.01% 620
2020
Q2 		$226K Sell
3,483
-390
-10% -$24.6K ﹤0.01% 715
2020
Q1 		$230K Sell
3,873
-1,637
-30% -$109K ﹤0.01% 650
2019
Q4 		$409K Sell
5,510
-240
-4% -$16.9K ﹤0.01% 556
2019
Q3 		$363K Buy
+5,750
New +$341K ﹤0.01% 603
2018
Q4 		– Sell
-12,944
Closed -$1.02M – 890
2018
Q3 		$1.02M Buy
12,944
+2,228
+21% +$159K 0.01% 394
2018
Q2 		$690K Sell
10,716
-3,154
-23% -$208K ﹤0.01% 440
2018
Q1 		$863K Buy
13,870
+7,595
+121% +$545K 0.01% 342
2017
Q4 		$455K Sell
6,275
-11,222
-64% -$816K ﹤0.01% 633
2017
Q3 		$1.42M Buy
17,497
+3,109
+22% +$246K 0.01% 213
2017
Q2 		$1.16M Buy
14,388
+9,440
+191% +$745K 0.01% 215
2017
Q1 		$388K Buy
+4,948
New +$395K ﹤0.01% 668
2016
Q3 		– Sell
-4,403
Closed -$422K – 691
2016
Q2 		$422K Sell
4,403
-199
-4% -$19.8K ﹤0.01% 402
2016
Q1 		$477K Sell
4,602
-892
-16% -$86.7K ﹤0.01% 254
2015
Q4 		$537K Buy
5,494
+166
+3% +$16.3K 0.01% 355
2015
Q3 		$5.14K Sell
5,328
-212
-4% -$22.3K 0.01% 324
2015
Q2 		$581K Buy
5,540
+81
+1% +$8.28K 0.01% 326
2015
Q1 		$563K Sell
5,459
-1,278
-19% -$129K ﹤0.01% 256
2014
Q4 		$649K Sell
6,737
-491
-7% -$43.3K 0.01% 217
2014
Q3 		$575K Sell
7,228
-880
-11% -$69.4K ﹤0.01% 408
2014
Q2 		$611K Buy
8,108
+208
+3% +$15.7K 0.01% 358
2014
Q1 		$591K Buy
+7,900
New +$558K 0.01% 294

Other funds holding CVS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

ALPS Advisors's CVS Position: Q1 2026 in Review

ALPS Advisors increased its CVS Health (CVS) stake by 9.6% in Q1 2026, buying an estimated $2.32M and bringing the position to 346,043 shares worth $24.9M. The position accounts for 0.12% of the portfolio, ranked #114.

ALPS Advisors first reported a position in CVS in Q1 2014 and has held it in 40 quarters since. The position peaked at $25.1M in Q4 2025. 1,865 funds tracked by Wall St. Rank hold CVS as of Q1 2026.

  • ALPS Advisors held 346,043 shares of CVS Health worth $24.9M as of Q1 2026.
  • ALPS Advisors bought 30,181 CVS Health shares in Q1 2026, an estimated $2.32M.
  • CVS Health made up 0.12% of ALPS Advisors's portfolio in Q1 2026, its #114 holding.
  • ALPS Advisors first reported a position in CVS Health in Q1 2014 and has held it in 40 quarters since.
  • ALPS Advisors's CVS Health position peaked at $25.1M in Q4 2025.
  • 1,865 funds tracked by Wall St. Rank held CVS Health as of Q1 2026.

Based on ALPS Advisors's 13F filing for Q1 2026, filed 8 May 2026.